Takahashi, Naoyuki

Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis

Maeda, K., Kobayashi, Y., Udagawa, N., Uehara, S., Ishihara, A., Mizoguchi, T., Kikuchi, Y., Takada, I., Kato, S., Kani, S., et al. (2012) · Nature Medicine

Bone Metabolism and DiseasesWnt/β-catenin signaling in development and cancer

Cited by 542

The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption

Yamada, C., Yamada, Y., Tsukiyama, K., Yamada, K., Udagawa, N., Takahashi, N., Tanaka, K., Drucker, D. J., Seino, Y., & Inagaki, N. (2008) · Endocrinology

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 318

Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions

Quinn, J. M. W., Itoh, K., Udagawa, N., Häusler, K., Yasuda, H., Shima, N., Mizuno, A., Higashio, K., Takahashi, N., Suda, T., et al. (2001) · Journal of Bone and Mineral Research

Bone Metabolism and DiseasesTGF-β signaling in diseases

Cited by 278

Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand

Itoh, K., Udagawa, N., Katagiri, T., Iemura, S., Ueno, N., Yasuda, H., Higashio, K., Quinn, J. M. W., Gillespie, M. T., Martin, T. J., et al. (2001) · Endocrinology

Bone Metabolism and DiseasesTGF-β signaling in diseases

Cited by 250

Gastric Inhibitory Polypeptide as an Endogenous Factor Promoting New Bone Formation after Food Ingestion

Tsukiyama, K., Yamada, Y., Yamada, C., Harada, N., Kawasaki, Y., Ogura, M., Bessho, K., Li, M., Amizuka, N., Sato, M., et al. (2006) · Molecular Endocrinology

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 198

Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.

Nakamura, M., Udagawa, N., Matsuura, S., Mogi, M., Nakamura, H., Horiuchi, H., Saito, N., Hiraoka, B. Y., Kobayashi, Y., Takaoka, K., et al. (2003) · Endocrinology

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 191

Action of RANKL and OPG for Osteoclastogenesis

Kobayashi, Y., Udagawa, N., & Takahashi, N. (2009) · Critical Reviews™ in Eukaryotic Gene Expression

Bone Metabolism and DiseasesOsteomyelitis and Bone Disorders Research

Cited by 176

Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling

Uehara, S., Udagawa, N., Mukai, H., Ishihara, A., Maeda, K., Yamashita, T., Murakami, K., Nishita, M., Nakamura, T., Kato, S., et al. (2017) · Science Signaling

Bone Metabolism and DiseasesWnt/β-catenin signaling in development and cancer

Cited by 83

Osteoprotegerin reduces the serum level of receptor activator of NF-κB ligand derived from osteoblasts.

Nakamichi, Y., Udagawa, N., Kobayashi, Y., Nakamura, M., Yamamoto, Y., Yamashita, T., Mizoguchi, T., Sato, M., Mogi, M., Penninger, J. M., et al. (2007) · The Journal of Immunology

Bone Metabolism and DiseasesNF-κB Signaling Pathways

Cited by 50

Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a

Kobayashi, Y., Thirukonda, G. J., Nakamura, Y., Koide, M., Yamashita, T., Uehara, S., Kato, H., Udagawa, N., & Takahashi, N. (2015) · Biochemical and Biophysical Research Communications

Bone Metabolism and DiseasesWnt/β-catenin signaling in development and cancer

Cited by 47